SFRP2 and osteogenesis imperfecta: There were also several WNT inhibitors (Sfrp2, Nkd2, and Frzb), which were upregulated in both OI groups, and Sfrp1 and Nkd1, which were upregulated only in oim/oim (Fig. 5B).